Turn Therapeutics Inc. Common Stock (NASDAQ:TTRX) — Stock Price

$9.60 USD
▼ -7.78% today

Turn Therapeutics Inc. Common Stock (NASDAQ:TTRX) is currently trading at $9.60 USD, down 7.78% today. Over the past 52 weeks, shares have ranged between $2.71 and $10.41. This page tracks Turn Therapeutics Inc. Common Stock's live share price on the NASDAQ exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Turn Therapeutics Inc. Common Stock market cap and net worth.

Turn Therapeutics Inc. Common Stock (TTRX) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Turn Therapeutics Inc. Common Stock's daily closing share price and trading volume on the NASDAQ exchange over the past year, giving a clear view of recent price momentum and liquidity.

Turn Therapeutics Inc. Common Stock Income Statement — Revenue, Profit & Earnings by Year

Turn Therapeutics Inc. Common Stock's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20242023
Total Revenue $0.00 $0.00
Cost of Revenue
Gross Profit
Research & Development $245.96K $7.50K
SG&A $1.55 Million $2.30 Million
Total Operating Expenses $1.80 Million $2.31 Million
Operating Income $-1.80 Million $-2.31 Million
EBITDA $-1.72 Million $-2.25 Million
EBIT $-1.77 Million $-2.29 Million
Interest Expense
Income Before Tax $-1.77 Million $-2.29 Million
Income Tax Expense
Net Income $-1.77 Million $-2.29 Million

Turn Therapeutics Inc. Common Stock Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Turn Therapeutics Inc. Common Stock's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 202520242023
Total Assets $12.16 Million $2.05 Million $2.01 Million
Total Current Assets $5.20 Million $1.10 Million $1.20 Million
Cash & Equivalents
Short-term Investments
Net Receivables
Inventory
Property, Plant & Equipment
Goodwill
Total Liabilities $7.48 Million $2.23 Million $1.93 Million
Total Current Liabilities $6.00 Million $707.93K $489.78K
Long-term Debt
Net Debt $-5.00 Million $-751.56K $-1.16 Million
Total Stockholder Equity $4.69 Million $-177.43K $85.77K
Retained Earnings $-22.39 Million $-19.20 Million $-17.43 Million

Turn Therapeutics Inc. Common Stock Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Turn Therapeutics Inc. Common Stock generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 202520242023
Operating Cash Flow $-2.56 Million $-1.36 Million $-1.38 Million
Capital Expenditures $152.99K $99.47K $44.31K
Free Cash Flow $-2.72 Million $-1.46 Million $-1.42 Million
Investing Cash Flow $-152.99K $-99.47K $-44.31K
Financing Cash Flow $6.92 Million $1.15 Million $500.00K
Dividends Paid
Stock-Based Compensation $419.25K $352.83K $640.26K
Depreciation $52.75K $47.48K $43.92K
Change in Cash $4.20 Million $-308.40K $-921.99K

Turn Therapeutics Inc. Common Stock Earnings History — EPS Actual vs. Analyst Estimates

Track Turn Therapeutics Inc. Common Stock's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Aug 10, 2026 -0.02
May 11, 2026 -0.04 -0.02 -100.00%
Mar 31, 2026 0.01
Nov 13, 2025 -0.07 0.00
Sep 16, 2025 -0.05 0.00